NASDAQ NMS - GLOBAL MARKET · BNTX
+0.83% · +$0.7400 · Vol Not reported
Pre-market · updated 06:21:18 ET
Biontech SE

Biontech SE

Biotechnology
$89.75
Card
Relationship Map

Follow $BNTX

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $BNTX by email

Veridion Score

BETAHIGH CONF · 6 of 6 factors measuredMethodology
BNTX
Biontech SE
Tue Oct 13 · last completed session · Pre-market · regular session opens 9:30 ET
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

45/ 100
Veridion Score
Middle range · HIGH confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →or $250/yr
Cancel anytime · or Reserve · $79/moor $790/yr
Confidence: HIGH · 6 of 6 factors measured · Tue Oct 13 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
AI Analysis
Sovereign

Why is BNTX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and available price action.
About Biontech SE
Biotechnology
Listed since
2019
Employees
8K
Country
DE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$89.01
Last session
Day high
$89.01
Last session
Day low
$89.01
Last session
Previous close
$89.01
52W high
$119.34
-24.79% from high
52W low
$83.89
17% of range
Market cap
$22.4B
EPS
$-6.7095
Beta
0.58
Shares out
251.2M
Avg volume
954.6K
VWAP
$89.01
Last session
Price history computed in-house
1W
-5.77%
1M
-9.22%
3M
-1.98%
1Y
-12.53%
YTD
-5.72%
SMA 50 $98.94 · below
SMA 200 $97.77 · below
52W position 17%

BNTX overview

Veridion Score
45
Registered · 2026-10-13
6 of 6 factors measured
Latest receipt rows
5
Josh Gottheimer · Sale
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around BNTX.Congress disclosuresOpen receipt and filing context for BNTX.MethodologyReview score inputs, coverage rules, and limitations.
Public disclosures

Congress activity in BNTX

Congress trackerOpen ticker disclosure ledger →

2 filers · 4 buys · 4 sells (0 labeled S (partial)) · Dec 5, 2023 to Aug 7, 2025 · House 8 / Senate 0

All available history · Latest 5 of 8 lines · Read Oct 14, 2026, 11:11 AM UTC

See all 8 trades, filters and CSV — Sovereign $25/mo
Federal contracts

BNTX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BNTX in this window.
Lobbying spend

BNTX lobbying filings, year to date.

Registered lobbying filings matched to Biontech SE.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BNTX in this window.
Analyst ratings
Sovereign unlock shows available analyst consensus for BNTX.
Veridion by email

Disclosure findings, methodology notes, and product updates when we have them. No fixed schedule yet. No advertising list resale.